Global Self-care Medical Devices Industry

Global Self-care Medical Devices Industry

  • April 2021 •
  • 160 pages •
  • Report ID: 5799583 •
  • Format: PDF
Abstract:
- Global Self-care Medical Devices Market to Reach $19.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Self-care Medical Devices estimated at US$13.2 Billion in the year 2020, is projected to reach a revised size of US$19.7 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Blood Pressure Monitors, one of the segments analyzed in the report, is projected to record a 7.7% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Holter Monitors segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 9.1% CAGR
- The Self-care Medical Devices market in the U.S. is estimated at US$3.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
- Body Temperature Monitors Segment to Record 5% CAGR
- In the global Body Temperature Monitors segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$494 Million in the year 2020 will reach a projected size of US$677 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.6 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period.

- Select Competitors (Total 46 Featured) -
  • Abbott Laboratories
  • Animas Corporation
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Bioptik Technology, Inc.
  • Coloplast A/S
  • Consort Medical PLC
  • DaVita Healthcare Partners, Inc.
  • DexCom, Inc.
  • Fitbit, Inc.
  • Garmin Ltd.
  • Gerresheimer AG
  • Hollister, Inc.
  • IA Collaborative Holdings, LLC
  • Insulet Corporation
  • Jawbone
  • Johnson & Johnson
  • Medical Components, Inc.
  • Medisana GmbH
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Midmark Corporation
  • Mortara Instrument, Inc.
  • Nike, Inc.
  • Nipro Corporation
  • Nipro Diagnostics, Inc.
  • Nova Biomedical Corporation
  • NxStage Medical, Inc.
  • Omron Healthcare, Inc.
  • Philips Healthcare
  • QRS Diagnostic
  • Roche Diagnostics (Schweiz) AG
  • RPC Bramlage GmbH
  • Sterimed Medical Devices Pvt., Ltd.
  • Tandem Diabetes Care, Inc.
  • Valeritas, Inc.
  • Welch Allyn, Inc.